Clinical Features and Risk Factors for Mortality in Patients with Stenotrophomonas maltophilia Infection
Flora
; 28(1):94-103, 2023.
Artículo
en Inglés
| EMBASE | ID: covidwho-2293633
ABSTRACT
Introduction:
It is important to know the risk factors for death in reducing mortality in patients with Stenotrophomonas maltophilia infections. The purpose of this study was to examine the risk factors associated with mortality in hospitalized patients with S. maltophilia infections. Material(s) and Method(s) Patients with S. maltophilia infections aged 18 years and older who were hospitalized in Haseki Research and Training between January 1, 2017, and April 30, 2022, were included in the study. The patients were divided into two groups, non-survivors and survivors, and the clinical features and laboratory parameters of the groups were compared. Mortality risk factors were analyzed by logistic and Cox regression analyses. Result(s) A total of 75 patients with S. maltophilia infections were included. The mortality rate was 38.6% (n= 29). Advanced age (OR= 1.05, 95% CI= 1.012-1.085, p= 0.009), COVID-19 pneumonia (OR= 9.52, 95% CI= 1.255-72.223, p= 0.029), and presence of central venous catheter (CVC) (OR= 18.25, 95% CI= 2.187-152.323, p= 0.007) were risk factors for death. Conclusion(s) Physicians should be aware of the potential risk of S. maltophilia infections for mortality, particularly in patients with predefined risk factors such as advanced age, the presence of CVC, and COVID-19. Performing CVC care in accordance with infection prevention and control measures and timely removal of CVC may be beneficial in reducing deaths due to S. maltophilia infection.Copyright © 2023 Bilimsel Tip Yayinevi. All rights reserved.
covid-19; Mortality; Risk factors; Stenotrophomonas maltophilia; abdominal infection; Acinetobacter baumannii; adult; aged; antibiotic sensitivity; antibiotic therapy; article; bacteremia; bladder catheterization; clinical feature; controlled study; coronavirus disease 2019; Enterobacter cloacae; Escherichia coli; female; Gram negative infection/dt [Drug Therapy]; hospital patient; human; in-hospital mortality; infectious disease specialist; Klebsiella pneumoniae; laboratory test; major clinical study; male; mortality rate; mortality risk; national health service; patient information; proportional hazards model; retrospective study; single blind procedure; urinary tract infection; ventilator associated pneumonia; ceftazidime/dt [Drug Therapy]; cotrimoxazole/dt [Drug Therapy]; levofloxacin/dt [Drug Therapy]; central venous catheter; endotracheal tube; Stenotrophomonas maltophilia infection/dt [Drug Therapy]
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
EMBASE
Tipo de estudio:
Estudio pronóstico
Idioma:
Inglés
Revista:
Flora
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS